Moving towards improved vaccines for Toxoplasma gondii
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Toxoplasma gondii is an intracellular parasitic protozoan that infects almost all warm-blooded animals and humans, resulting in threats to public health and economic losses. Despite continuous research efforts, there are still very few effective strategies against toxoplasmosis. In the past few years, numerous vaccination experiments have been performed to control T. gondii infection. AREAS COVERED: In this review, the authors summarize the development of T. gondii vaccines with proper adjuvants, ranging from live or live-attenuated vaccines to protein vaccines, DNA vaccines, epitope vaccines and novel vaccines. They also highlight the challenges involved in the development of T. gondii vaccines, including specific impediments and shortcomings. EXPERT OPINION: Moving towards the development of effective vaccines against T. gondii is not only a tedious mission but also a difficult challenge. Future studies should consider new approaches and strategies for vaccine development, particularly novel vaccines and genetic adjuvants, as well as optimizing immunization protocols and evaluation criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Carbohydrate vaccines: developing sweet solutions to sticky situations?
Astronomo, R. D., & Burton, D. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3012 · Cited by 629
Peptide-based synthetic vaccines
Skwarczynski, M., & Toth, I. (2016) · Chemical Science · doi:10.1039/c5sc03892h · Cited by 596 · cited 1×
“In addition, multi-epitope vaccines more accurately mimic antigen processing and presentation during a natural infection and thus induce more efficient protective immunity than whole-protein vaccines [49].”
BackgroundChahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., Sidik, S. M., Lourido, S., Langer, R., Bavari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600299113 · Cited by 414 · cited 1×
“developed a rapid-response, fully synthetic, single-dose, adjuvant-free dendrimer nanoparticle vaccine platform wherein antigens are encoded by encapsulated mRNA replicons [56].”
Background
Cited by
Advances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development
Chu, K.-B., & Quan, F.-S. (2021) · Vaccines · doi:10.3390/vaccines9050413 · Cited by 92
Toxoplasmosis vaccines: what we have and where to go?
Zhang, Y., Li, D., Lu, S., & Zheng, B. (2022) · npj Vaccines · doi:10.1038/s41541-022-00563-0 · Cited by 77
Zheng, B., Lou, D., Ding, J., Zhuo, X., Ding, H., Kong, Q., & Lu, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00418 · Cited by 37
Protective immunity induced by TgMIC5 and TgMIC16 DNA vaccines against toxoplasmosis
Zhu, Y.-C., Ma, L.-J., Zhang, J.-L., Liu, J.-F., He, Y., Feng, J.-Y., & Chen, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.686004 · Cited by 16
Metadata
- Authors
- Li, Y., & Zhou, H.
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa UK Limited
- Published
- 2017-12-08
- Volume
- 18
- Issue
- 3
- Pages
- 273-280
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W2774817803
- Cited by
- 77
- References
- 4
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moving towards improved vaccines for Toxoplasma gondii. https://app.cochat.ai/papers/10.1080/14712598.2018.1413086
- The paper
- Li, Y., & Zhou, H. (2018). Moving towards improved vaccines for Toxoplasma gondii. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2018.1413086
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.